Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.33 -0.27 (-0.69%)
As of: Oct 1, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Return on Equity [ROE] (2009 - 2026)

Updated

Teva Pharmaceutical Industries (TEVA) recorded Return on Equity [ROE] of 8.87% in Q2 2026, up 11.34 percentage points from -2.47% a year earlier but down 10.54 percentage points from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Return on Equity [ROE] (2009 - 2026) Analysis & Trends

For FY2025, Teva Pharmaceutical Industries reported Return on Equity [ROE] of 21.33%, up 50.34 percentage points from FY2024.

  • Annual Return on Equity [ROE] has a five-year change of +52.71 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -29.01% in FY2024 (-21.65 pp), -7.35% in FY2023 (+17.83 pp), -25.19% in FY2022 (-29.28 pp) and 4.09% in FY2021 (+35.47 pp).
  • Quarterly Return on Equity [ROE] has ranged from -33.29% in Q4 2024 to 19.41% in Q1 2026 over the past five years.
  • On a year-over-year basis, Return on Equity [ROE] has increased for five consecutive quarters, with an average year-over-year change of +14.64 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 51.99 percentage points in Q4 2025, against a drop of 31.63 percentage points in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at 19.41% (Q1 2026), 18.70% (Q4 2025) and 9.40% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Teva Pharmaceutical Industries 46.10 Bn 32.95 Bn 2.15 Bn 8.87%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.87%
Mar 31, 2026 19.41%
Dec 31, 2025 18.70%
Sep 30, 2025 9.40%
Jun 30, 2025 -2.47%
Mar 31, 2025 -22.65%
Dec 31, 2024 -33.29%
Sep 30, 2024 -18.79%
Jun 30, 2024 -10.62%
Mar 31, 2024 -9.97%
Dec 31, 2023 -7.93%
Sep 30, 2023 -32.25%
Jun 30, 2023 -30.18%
Mar 31, 2023 -21.06%
Dec 31, 2022 -27.62%
Sep 30, 2022 -13.66%
Jun 30, 2022 -10.76%
Mar 31, 2022 -5.40%
Dec 31, 2021 4.01%
Sep 30, 2021 6.76%
API Access

Teva Pharmaceutical Industries Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TEVA&period=max&api_key=YOUR_API_KEY